Jana Medical Company (TADAWUL:9616)
Saudi Arabia
· Delayed Price · Currency is SAR
15.50
-0.04 (-0.26%)
Aug 14, 2025, 2:47 PM AST
Jana Medical Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 50 | 138 | - | - |
| Enterprise Value | 60 | 174 | - | - |
| Last Close Price | 15.50 | 42.90 | - | - |
| PS Ratio | 1.36 | 3.75 | - | - |
| PB Ratio | 1.27 | 3.51 | - | - |
| P/TBV Ratio | 1.27 | 3.52 | - | - |
| P/FCF Ratio | 9.37 | 25.92 | - | - |
| P/OCF Ratio | 9.35 | 25.88 | - | - |
| EV/Sales Ratio | 1.65 | 4.75 | - | - |
| EV/FCF Ratio | 11.37 | 32.77 | - | - |
| Debt / Equity Ratio | 0.74 | 0.74 | 0.92 | 0.83 |
| Debt / EBITDA Ratio | - | - | 2.58 | 3.29 |
| Debt / FCF Ratio | 5.47 | 5.47 | - | - |
| Asset Turnover | 0.45 | 0.45 | 0.87 | - |
| Inventory Turnover | 9.19 | 9.19 | 5.14 | - |
| Quick Ratio | 1.94 | 1.94 | 2.01 | 1.65 |
| Current Ratio | 2.17 | 2.17 | 2.19 | 2.16 |
| Return on Equity (ROE) | -61.32% | -61.32% | 16.19% | - |
| Return on Assets (ROA) | -4.03% | -4.03% | 11.10% | - |
| Return on Capital (ROIC) | -4.75% | -4.75% | 12.47% | - |
| Return on Capital Employed (ROCE) | - | - | 29.10% | 21.60% |
| Earnings Yield | -46.54% | -16.81% | - | - |
| FCF Yield | 10.68% | 3.86% | - | - |
| Buyback Yield / Dilution | -3.22% | -3.22% | -27.82% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.